From an oral or jaw infection, a small, anaerobic organism that appears as gram-negative diplococci fits Veillonella best. Veillonella are tiny gram-negative cocci that commonly occur in pairs (diplococci) and are strict anaerobes, part of the normal oral flora and often recovered in polymicrobial dental infections. The other options don’t match both the shape and the gram reaction: Peptostreptococcus is gram-positive cocci, while Bacteroides and Porphyromonas are gram-negative rods, not diplococci. So the combination of small size, diplococcal arrangement, and anaerobic nature points to Veillonella.

LAP score measures alkaline phosphatase activity in neutrophils. In chronic myeloid leukemia, neutrophils arise from a malignant clone with impaired maturation and reduced enzyme activity, so the LAP score is typically decreased. This helps distinguish CML from a leukemoid reaction, where neutrophils are highly activated and the LAP score is elevated. Hence the statement that LAP score is typically decreased is true.

This item is about detecting antibodies by binding prepared antigens to inert carriers and looking for clumping. In passive agglutination, antigens are artificially attached to particles such as latex beads. When the patient’s serum contains the specific antibody, those antibodies bind to the antigens on multiple particles and cross-link them, producing visible agglutination. This approach increases sensitivity and provides a straightforward visual readout because the antigen is presented on a solid phase, yet the antibody in the sample is what drives the clumping. Other methods differ in where the antigen is located or how the reaction is read. Direct agglutination uses antigens already present on particles like cells or bacteria, not treated to coat a separate carrier. Agglutination inhibition involves soluble antigen that blocks the clumping reaction, so a lack of agglutination indicates antibodies are present. Coagglutination uses a carrier such as bacteria to facilitate cross-linking. Thus, the technique described—antigens artificially coated on particles to detect antibodies—aligns with passive agglutination.

The test is about recognizing which EBV antibody signal best marks a new, active infection. When the body first encounters EBV, it rapidly makes IgM antibodies to the viral capsid antigen (VCA). Anti-VCA IgM rises early during acute illness and then declines over weeks to months, making it a clear indicator of a current infection. In contrast, anti-VCA IgG also appears early but remains for life, so its presence alone doesn’t prove the infection is new. Antibodies to EBNA appear later, indicating past infection or latency rather than acute disease. Early antigen (EA) antibodies can be present during active replication but are less consistently present and less specific for acute infection. So, anti-VCA IgM is the best marker for indicating an acute EBV infection because it appears promptly during the active phase and is more specific to recent infection than the other markers.

In steam sterilization, the key is achieving a high enough temperature with pressurized steam for an adequate exposure time. A standard autoclave runs at about 15 psi, which brings the temperature to roughly 121°C, and holding that heat for about 15 minutes is a well-established parameter to achieve sterility for typical loads. So describing a cycle with 15 psi for 15 minutes matches what is routinely used for steam sterilization. Ethylene oxide is a different sterilization method and not used with steam autoclaves. A maximum temperature of 100°C would not reach the necessary 121°C in a standard autoclave. Dry heat for 20 minutes is another separate method, involving dry heat rather than steam. Therefore, the statement about 15 psi for 15 minutes best describes a valid steam sterilization parameter.